Dermapharm Holding SE (FRA:DMP)

Market Cap	1.77B
Revenue (ttm)	1.19B
Net Income (ttm)	107.20M
Shares Out	n/a
EPS (ttm)	1.99
PE Ratio	16.52
Forward PE	13.70
Dividend	0.90 (2.73%)
Ex-Dividend Date	Jun 27, 2025

Volume	13,680
Average Volume	21,894
Open	33.00
Previous Close	33.00
Day's Range	32.70 - 33.20
52-Week Range	30.15 - 42.50
Beta	n/a
RSI	43.63
Earnings Date	Aug 26, 2025

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as product...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,610
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: DMP

Financial Performance

In 2024, Dermapharm Holding SE's revenue was 1.20 billion, an increase of 3.89% compared to the previous year's 1.15 billion. Earnings were 113.79 million, an increase of 82.44%.